Skip to content
healthcare.dev

Lacosamide Oral Solution

NDC 82983-427, Lacosamide, solution, from Ajenat Pharmaceuticals LLC.

Product NDC
82983-427
Status
Listed
Labeler
Ajenat Pharmaceuticals LLC
Dosage form
SOLUTION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219699
DEA schedule
CV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82983-427 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LACOSAMIDE10 mg/mL

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
82983-427-3182983042731200 mL in 1 BOTTLE, PLASTIC (82983-427-31)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/cb29da34-89aa-405a-8fbc-2308bda37187
  • NADAC price for package 82983042731

    GET /v1/drugs/nadac/82983042731

Use it

Look up 82983-427 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82983-427 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82983-427. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.